Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells ; volume:16 ; number:1 ; day:26 ; month:9 ; year:2016 ; pages:1-8 ; date:12.2016
BMC complementary and alternative medicine ; 16, Heft 1 (26.9.2016), 1-8, 12.2016
- Creator
-
Park, Gwang Hun
- Contributor
-
Sung, Ji Ho
Song, Hun Min
Jeong, Jin Boo
SpringerLink (Online service)
- DOI
-
10.1186/s12906-016-1364-x
- URN
-
urn:nbn:de:1111-201611036063
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Gwang Hun
- Sung, Ji Ho
- Song, Hun Min
- Jeong, Jin Boo
- SpringerLink (Online service)
Other Objects (12)
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Elevated expression of CDK4 in lung cancer
CDK4/6 inhibition in luminal breast cancer
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis
The role of targeting CDK4/6 in cancer immunotherapy
TEX19 increases the levels of CDK4 and promotes breast cancer by disrupting SKP2-mediated CDK4 ubiquitination
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Elevated expression of CDK4 in lung cancer
CDK4/6 inhibition in luminal breast cancer
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis
The role of targeting CDK4/6 in cancer immunotherapy
TEX19 increases the levels of CDK4 and promotes breast cancer by disrupting SKP2-mediated CDK4 ubiquitination
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Elevated expression of CDK4 in lung cancer
CDK4/6 inhibition in luminal breast cancer
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis
The role of targeting CDK4/6 in cancer immunotherapy